Izaskun Valduvieco1, Albert Biete1, Luis A Moreno2, Xavier Gallart3, Angels Rovirosa1, Jordi Saez2, Carlos Plana4, Pilar Peris4. 1. 1 Department of Radiation Oncology, Hospital Clínic, Institute of Haematology and Oncology, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain. 2. 2 Surgical Area, Anesthesia Service, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain. 3. 3 Traumatology Service, Hospital Clínic, Institute of Medical and Surgical Specialties, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain. 4. 4 Department of Rheumatology, Hospital Clínic, Institute of Medical and Surgical Specialties, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.
Abstract
OBJECTIVE: To evaluate the analgesic efficacy of low-dose radiotherapy in refractory cases of trochanteritis. METHODS: We evaluated a total of 60 consecutive patients who received low-dose radiotherapy to achieve an anti-inflammatory and analgesic effect for recurrent trochanteritis following scarce response to conventional therapy. All patients were evaluated at baseline (prior to radiotherapy) and at 1 and 4 months after radiotherapy and then yearly thereafter for pain assessment using a visual analogue scale (VAS) and to determine the administration of analgesic treatment. RESULTS: An improvement in the symptomatology was observed in 62% of the patients with a significant reduction in the VAS (8 ± 2 vs 4 ± 2; p < 0.0001), which was largely maintained until the second evaluation at 4 months. In the cases responding to radiotherapy, the probability of maintaining improvement beyond 24 months was 70%. CONCLUSION: Low-dose anti-inflammatory radiation may be used in the treatment of the recurrent cases of relapse or no response of trochanteritis to conventional treatments, with a high probability of remission of pain. These preliminary results indicate the need for evaluating the use of radiotherapy in patients with trochanteritis refractory to conventional treatment in a long-term controlled study. Advances in knowledge: Radiotherapy provides effective analgesic treatment for patients refractory to standard treatment for trochanteritis.
OBJECTIVE: To evaluate the analgesic efficacy of low-dose radiotherapy in refractory cases of trochanteritis. METHODS: We evaluated a total of 60 consecutive patients who received low-dose radiotherapy to achieve an anti-inflammatory and analgesic effect for recurrent trochanteritis following scarce response to conventional therapy. All patients were evaluated at baseline (prior to radiotherapy) and at 1 and 4 months after radiotherapy and then yearly thereafter for pain assessment using a visual analogue scale (VAS) and to determine the administration of analgesic treatment. RESULTS: An improvement in the symptomatology was observed in 62% of the patients with a significant reduction in the VAS (8 ± 2 vs 4 ± 2; p < 0.0001), which was largely maintained until the second evaluation at 4 months. In the cases responding to radiotherapy, the probability of maintaining improvement beyond 24 months was 70%. CONCLUSION: Low-dose anti-inflammatory radiation may be used in the treatment of the recurrent cases of relapse or no response of trochanteritis to conventional treatments, with a high probability of remission of pain. These preliminary results indicate the need for evaluating the use of radiotherapy in patients with trochanteritis refractory to conventional treatment in a long-term controlled study. Advances in knowledge: Radiotherapy provides effective analgesic treatment for patients refractory to standard treatment for trochanteritis.
Authors: Aaltien Brinks; Rogier M van Rijn; Sten P Willemsen; Arthur M Bohnen; Jan A N Verhaar; Bart W Koes; Sita M A Bierma-Zeinstra Journal: Ann Fam Med Date: 2011 May-Jun Impact factor: 5.166
Authors: Arshin Sheybani; Mindi J TenNapel; William D Lack; Patrick Clerkin; Daniel E Hyer; Wenqing Sun; Geraldine M Jacobson Journal: Int J Radiat Oncol Biol Phys Date: 2014-05-03 Impact factor: 7.038
Authors: Lisa Deloch; Anja Derer; Axel J Hueber; Martin Herrmann; Georg Andreas Schett; Jens Wölfelschneider; Jonas Hahn; Paul-Friedrich Rühle; Willi Stillkrieg; Jana Fuchs; Rainer Fietkau; Benjamin Frey; Udo S Gaipl Journal: Front Immunol Date: 2018-09-18 Impact factor: 7.561